CLNINDIA.NS
Clariant Chemicals (India) Limited [CLNINDIA.NS] Stock Forecast
Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
CLNINDIA.NS Stock Summary
In the News
CLNINDIA.NS Financial details
Company Rating
Strong Buy
Market Cap
7.38B
Income
261.3M
Revenue
7.88B
Book val./share
-
Cash/share
-
Dividend
-
Dividend %
-
Employees
498
Optionable
No
Shortable
Yes
Earnings
22 May 2023
P/E
-730.62
Forward P/E
-
PEG
82.92
P/S
2.01
P/B
1.77
P/C
-
P/FCF
-
Quick Ratio
1.16
Current Ratio
2.33
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
11.32
EPS next Y
-
EPS next Q
-
EPS this Y
-80.29%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
14.93%
Revenue last 5Y
-3.68%
Revenue Q/Q
-5.39%
EPS Q/Q
-186.87%
-
-
-
-
SMA20
-2.48%
SMA50
-13.7%
SMA100
-
Inst Own
-
Inst Trans
-
ROA
-
ROE
-
ROC
0.05%
Gross Margin
38%
Oper. Margin
5%
Profit Margin
-
Payout
-
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
302.0-528.0
52W High
-39.48%
52W Low
+5.81%
RSI
51
Rel Volume
0.47
Avg Volume
18.04K
Volume
8.42K
Perf Week
3.77%
Perf Month
-3.76%
Perf Quarter
-
Perf Half Y
-20.16%
-
-
-
-
Beta
0.81203
-
-
Volatility
4.44%, 7.93%
Prev Close
0%
Price
319.55
Change
-0.16%
CLNINDIA.NS Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2022-03-31
| Metric | History | 2018-03-31 | 2019-03-31 | 2020-03-31 | 2021-03-31 | 2022-03-31 |
|---|---|---|---|---|---|---|
| 2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
| Revenue per share | 433.94 | 438.65 | 322.63 | 311.32 | 359.7 | |
| Net income per share | 9.36 | 8.04 | 8.04 | 95.21 | 18.77 | |
| Operating cash flow per share | -0.42 | 12.9 | 42.94 | 24.55 | 5.69 | |
| Free cash flow per share | -13.03 | -1.13 | 32.28 | 20.41 | -3.03 | |
| Cash per share | 26.38 | 17.42 | 46.43 | 14.69 | 7.03 | |
| Book value per share | 270.61 | 267.06 | 282.22 | 176.42 | 179.3 | |
| Tangible book value per share | 249.75 | 246.78 | 278.34 | 172.55 | 175.43 | |
| Share holders equity per share | 270.61 | 267.06 | 282.22 | 176.42 | 179.3 | |
| Interest debt per share | 0.26 | 0.27 | 15.6 | 1.36 | 0.29 | |
| Market cap | 7.38B | 7.38B | 7.38B | 7.38B | 7.38B | |
| Enterprise value | 7.17B | 7.09B | 7.44B | 7.14B | 7.31B | |
| P/E ratio | 34.15 | 39.74 | 39.75 | 3.36 | 17.03 | |
| Price to sales ratio | 0.74 | 0.73 | 0.99 | 1.03 | 0.89 | |
| POCF ratio | -759.53 | 24.77 | 7.44 | 13.01 | 56.12 | |
| PFCF ratio | -24.53 | -283.28 | 9.9 | 15.66 | -105.34 | |
| P/B Ratio | 1.18 | 1.2 | 1.13 | 1.81 | 1.78 | |
| PTB ratio | 1.18 | 1.2 | 1.13 | 1.81 | 1.78 | |
| EV to sales | 0.72 | 0.7 | 1 | 0.99 | 0.88 | |
| Enterprise value over EBITDA | 10.34 | 10.63 | 9.22 | 2.05 | 11.45 | |
| EV to operating cash flow | -738.79 | 23.82 | 7.51 | 12.6 | 55.61 | |
| EV to free cash flow | -23.86 | -272.48 | 9.98 | 15.16 | -104.38 | |
| Earnings yield | 0.03 | 0.03 | 0.03 | 0.3 | 0.06 | |
| Free cash flow yield | -0.04 | 0 | 0.1 | 0.06 | -0.01 | |
| Debt to equity | 0 | 0 | 0.05 | 0 | 0 | |
| Debt to assets | 0 | 0 | 0.03 | 0 | 0 | |
| Net debt to EBITDA | -0.29 | -0.42 | 0.08 | -0.07 | -0.11 | |
| Current ratio | 2 | 1.9 | 2.51 | 1.86 | 1.95 | |
| Interest coverage | 52.97 | 47.02 | 9.37 | 120.25 | 91.82 | |
| Income quality | -0.03 | 0.99 | 1.4 | 0.18 | 0.27 | |
| Dividend Yield | 0.09 | 0.04 | 0.02 | 0.63 | 0.05 | |
| Payout ratio | 3.22 | 1.5 | 0.62 | 2.11 | 0.8 | |
| Sales general and administrative to revenue | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | |
| Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
| Intangibles to total assets | 0.05 | 0.05 | 0.01 | 0.01 | 0.01 | |
| Capex to operating cash flow | 29.96 | -1.09 | -0.25 | -0.17 | -1.53 | |
| Capex to revenue | -0.03 | -0.03 | -0.03 | -0.01 | -0.02 | |
| Capex to depreciation | -0.77 | -0.87 | -0.55 | -0.27 | -0.99 | |
| Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
| Graham number | 238.7 | 219.81 | 225.94 | 614.77 | 275.17 | |
| ROIC | 0.03 | 0.03 | 0.03 | 0.53 | 0.09 | |
| Return on tangible assets | 0.03 | 0.02 | 0.02 | 0.34 | 0.07 | |
| Graham Net | 24.79 | 18.54 | 76.91 | 20.92 | 21.09 | |
| Working capital | 2.36B | 2.26B | 3.8B | 1.97B | 1.98B | |
| Tangible asset value | 5.76B | 5.7B | 6.42B | 3.98B | 4.05B | |
| Net current asset value | 2.02B | 1.98B | 3.4B | 1.83B | 1.85B | |
| Invested capital | 0 | 0 | 0.05 | 0 | 0 | |
| Average receivables | 2.07B | 2.46B | 3.26B | 3.26B | 2.46B | |
| Average payables | 1.76B | 1.86B | 1.62B | 1.57B | 1.74B | |
| Average inventory | 1.62B | 1.76B | 1.55B | 1.3B | 1.42B | |
| Days sales outstanding | 87.62 | 90.81 | 195.75 | 127.9 | 105.39 | |
| Days payables outstanding | 100.52 | 103.06 | 104.76 | 148.87 | 115.64 | |
| Days of inventory on hand | 92.01 | 99.96 | 97.28 | 112.38 | 101.92 | |
| Receivables turnover | 4.17 | 4.02 | 1.86 | 2.85 | 3.46 | |
| Payables turnover | 3.63 | 3.54 | 3.48 | 2.45 | 3.16 | |
| Inventory turnover | 3.97 | 3.65 | 3.75 | 3.25 | 3.58 | |
| ROE | 0.03 | 0.03 | 0.03 | 0.54 | 0.1 | |
| Capex per share | -12.61 | -14.03 | -10.65 | -4.15 | -8.73 |
Quarterly Fundamentals Overview
Last date of statement is 2022-12-31 for Q3
| Metric | History | 2021-12-31 | 2022-03-31 | 2022-06-30 | 2022-09-30 | 2022-12-31 |
|---|---|---|---|---|---|---|
| 2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
| Revenue per share | 96.07 | 86.97 | 95.36 | 81.65 | 77.19 | |
| Net income per share | 3.66 | 7.02 | 4.74 | -3.35 | 2.91 | |
| Operating cash flow per share | 0 | 0 | 0 | 0 | 0 | |
| Free cash flow per share | 0 | 0 | 0 | 0 | 0 | |
| Cash per share | 0 | 7.03 | 0 | 17.62 | 0 | |
| Book value per share | 0 | 179.26 | 0 | 180.73 | 0 | |
| Tangible book value per share | 0 | 175.39 | 0 | 176.85 | 0 | |
| Share holders equity per share | 0 | 179.26 | 0 | 180.73 | 0 | |
| Interest debt per share | 0 | 0.13 | 0 | 0.05 | 0 | |
| Market cap | 7.38B | 7.38B | 7.38B | 7.37B | 7.38B | |
| Enterprise value | 0 | 7.31B | 0 | 7.02B | 0 | |
| P/E ratio | 21.83 | 11.39 | 16.85 | -23.85 | 27.45 | |
| Price to sales ratio | 3.33 | 3.67 | 3.35 | 3.91 | 4.14 | |
| POCF ratio | 0 | 0 | 0 | 0 | 0 | |
| PFCF ratio | 0 | 0 | 0 | 0 | 0 | |
| P/B Ratio | 0 | 1.78 | 0 | 1.77 | 0 | |
| PTB ratio | 0 | 1.78 | 0 | 1.77 | 0 | |
| EV to sales | 0 | 3.64 | 0 | 3.73 | 0 | |
| Enterprise value over EBITDA | 0 | 41.45 | 0 | 43.97 | 0 | |
| EV to operating cash flow | 0 | 0 | 0 | 0 | 0 | |
| EV to free cash flow | 0 | 0 | 0 | 0 | 0 | |
| Earnings yield | 0.01 | 0.02 | 0.01 | -0.01 | 0.01 | |
| Free cash flow yield | 0 | 0 | 0 | 0 | 0 | |
| Debt to equity | 0 | 0 | 0 | 0 | 0 | |
| Debt to assets | 0 | 0 | 0 | 0 | 0 | |
| Net debt to EBITDA | 0 | -0.38 | 0 | -2.2 | 0 | |
| Current ratio | 0 | 1.95 | 0 | 2.33 | 0 | |
| Interest coverage | 68.47 | 133.82 | 184.88 | 135 | 143.67 | |
| Income quality | 0 | 0 | 0 | 0 | 0 | |
| Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
| Payout ratio | 0 | 0 | 0 | 0 | 0 | |
| Sales general and administrative to revenue | 0 | 0 | 0 | 0 | 0 | |
| Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
| Intangibles to total assets | 0 | 0.01 | 0 | 0.02 | 0 | |
| Capex to operating cash flow | 0 | 0 | 0 | 0 | 0 | |
| Capex to revenue | 0 | 0 | 0 | 0 | 0 | |
| Capex to depreciation | 0 | 0 | 0 | 0 | 0 | |
| Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
| Graham number | 0 | 168.23 | 0 | 116.71 | 0 | |
| ROIC | 0 | 0.04 | 0 | -0.05 | 0 | |
| Return on tangible assets | 0 | 0.03 | 0 | -0.01 | 0 | |
| Graham Net | 0 | 21.09 | 0 | 17.21 | 0 | |
| Working capital | 0 | 1.98B | 0 | 2.17B | 0 | |
| Tangible asset value | 0 | 4.05B | 0 | 4.08B | 0 | |
| Net current asset value | 0 | 1.85B | 0 | 2.03B | 0 | |
| Invested capital | 0 | 0 | 0 | 0 | 0 | |
| Average receivables | 0 | 0 | 0 | 0 | 0 | |
| Average payables | 0 | 0 | 0 | 0 | 0 | |
| Average inventory | 0 | 0 | 0 | 0 | 0 | |
| Days sales outstanding | 0 | 107.45 | 0 | 71.29 | 0 | |
| Days payables outstanding | 0 | 114.08 | 0 | 97.19 | 0 | |
| Days of inventory on hand | 0 | 100.54 | 0 | 98.19 | 0 | |
| Receivables turnover | 0 | 0.84 | 0 | 1.26 | 0 | |
| Payables turnover | 0 | 0.79 | 0 | 0.93 | 0 | |
| Inventory turnover | 0 | 0.9 | 0 | 0.92 | 0 | |
| ROE | 0 | 0.04 | 0 | -0.02 | 0 | |
| Capex per share | 0 | 0 | 0 | 0 | 0 |
CLNINDIA.NS Frequently Asked Questions
What is Clariant Chemicals (India) Limited stock symbol ?
Clariant Chemicals (India) Limited is a IN stock and trading under the symbol CLNINDIA.NS
What is Clariant Chemicals (India) Limited stock quote today ?
Clariant Chemicals (India) Limited stock price is $319.55 today.
Is Clariant Chemicals (India) Limited stock public?
Yes, Clariant Chemicals (India) Limited is a publicly traded company.
Company Profile
- Volume Average 18.04K
- Market Capitalization 7.38B
- Employee 498
- CEO Mr. Bharath R. Sesha
- Headquarters Navi Mumbai,IN
- IPO Date 1995-01-19
-
Website
https://www.clariant.com/pigments 
Clariant Chemicals (India) Limited manufactures and sells specialty chemicals in India and internationally. The company operates in two segments, Plastics and Coatings, and Specialty Chemicals. It offers organic pigments, pigment preparations, and dyes used in the automotive industry; industrial and architectural coatings; color home and fabric care products for plastics industry; and other applications including seed coloration, traditional, and digital printing. The company also provides dyestuffs, synthetic resins, functional effects and coatings, and auxiliaries and chemicals. The company was formerly known as Colour-Chem Limited and changed its name to Clariant Chemicals (India) Limited in 2006. Clariant Chemicals (India) Limited was incorporated in 1956 and is headquartered in Navi Mumbai, India.
